Clinical trial
Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected…
NCT00120783 · French National Agency for Research on AIDS and Viral Hepatitis, Other · Terminated
Key facts
| NCT number | NCT00120783 |
|---|---|
| Title | Efficacy and Tolerability of an Antiretroviral Bi-Therapy in HIV Infected Patients With Multidrug Resistance |
| Official title | Efficacy and Tolerability of an Antiretroviral bi-Therapy in HIV-1 Infected Patients With Multidrug Resistant HIV ANRS 109 Vista Trial. |
| Lead sponsor | French National Agency for Research on AIDS and Viral Hepatitis, Other |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | HIV Infections |
| Intervention type | Drug |
| Interventions | Indinavir, Lamivudine, Ritonavir |
| Enrollment | 40 |
| Start date | Feb 1, 2002 |
| Completion | Aug 1, 2003 |
| First posted | Jul 19, 2005 |
| Last update posted | Jan 18, 2007 |
| Countries | France |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: